Jude C. Dike

FDA investigator

Appears on 9 documents from 2015 to 2022, mostly at sites in Maryland. Most often cites corrective and preventive action (21 CFR 820.100).

9
Documents on file
3.4
Observations per 483
2015
First seen
2022
Most recent

What they cite most

From 31 observations

Activity by year

2015: 2, 2018: 2, 2019: 2, 2021: 2, 2022: 1

Where

Maryland 5 · California 3 · Texas 1

Is Jude C. Dike coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 Maiden BiosciencesNov 28, 2022 · Gaithersburg, Maryland
483 Life Technologies CorporationJun 14, 2021 · Frederick, Maryland
483 Life Technologies Corporation 7335Jun 14, 2021 · Frederick, Maryland
483 Tetracore, IncDec 6, 2019 · Rockville, Maryland
483 Clear Guide Medical, IncNov 13, 2019 · Baltimore, Maryland
483 Swiss-American CDMO, LLCSep 28, 2018 · Carrollton, Texas
483 Pontis Orthopaedics, LLCJul 5, 2018 · San Francisco, California

About this profile

What does Jude C. Dike inspect?

Jude C. Dike appears on 9 documents on file covering 8 sites, mostly in Maryland.

What do they cite most often?

21 CFR 820.100 (corrective and preventive action), followed by 21 CFR 820.70 and 21 CFR 820.20(b)(3).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jude C. Dike is dated Nov 28, 2022.